Literature DB >> 27600639

Obesity-related changes in clinical parameters and conditions in a longitudinal population-based epidemiological study.

Mitsutoshi Oguri1, Tetsuo Fujimaki2, Hideki Horibe3, Kimihiko Kato4, Kota Matsui5, Ichiro Takeuchi6, Yoshiji Yamada7.   

Abstract

OBJECTIVES: The purpose of the present study was to examine the association of body mass index (BMI) or obesity with various clinical parameters and conditions in a longitudinal population-based epidemiological study in Japan.
METHODS: Study subjects comprised 6027 community-dwelling individuals who were recruited to the Inabe Health and Longevity Study, a longitudinal genetic epidemiological study of atherosclerotic, cardiovascular, and metabolic diseases. Obesity was defined as BMI ≥25kg/m2.
RESULTS: Longitudinal analysis with the generalised linear mixed-effect model after adjustment for age showed that for men, BMI was significantly (P<0.0008) related to systolic, diastolic, and mean blood pressure and serum concentrations of high-density lipoprotein (HDL)-cholesterol and low-density lipoprotein (LDL)-cholesterol. For women, BMI was also significantly related to serum concentrations of triglycerides, HDL-cholesterol, and LDL-cholesterol. Longitudinal analysis with the generalised estimating equation with adjustment for age showed that in men, BMI was significantly (P<0.0012) associated with the prevalence of hypertension, type 2 diabetes mellitus, hypertriglyceridemia, hypo-HDL-cholesterolemia, decreased estimated glomerular filtration rate, and hyperuricemia. In women, BMI was also significantly associated with the prevalence of hypertension, type 2 diabetes mellitus, hypertriglyceridemia, and hyperuricemia.
CONCLUSION: Obesity has detrimental effects on various clinical parameters and conditions, resulting in increased risk of hypertension, dyslipidemia, type 2 diabetes mellitus, hyperuricemia, and chronic kidney disease.
Copyright © 2016 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body mass index; Clinical parameters; Longitudinal study; Obesity

Mesh:

Substances:

Year:  2016        PMID: 27600639     DOI: 10.1016/j.orcp.2016.08.008

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  6 in total

1.  Pathways linking obesity to health-related quality of life.

Authors:  Sangshin Park
Journal:  Qual Life Res       Date:  2017-04-05       Impact factor: 4.147

2.  Social marketing including financial incentive programs at worksite cafeterias for preventing obesity: a systematic review.

Authors:  Kimi Sawada; Koji Wada; Sadequa Shahrook; Erika Ota; Yukari Takemi; Rintaro Mori
Journal:  Syst Rev       Date:  2019-02-28

3.  Evolutionary history of disease-susceptibility loci identified in longitudinal exome-wide association studies.

Authors:  Yoshiki Yasukochi; Jun Sakuma; Ichiro Takeuchi; Kimihiko Kato; Mitsutoshi Oguri; Tetsuo Fujimaki; Hideki Horibe; Yoshiji Yamada
Journal:  Mol Genet Genomic Med       Date:  2019-08-11       Impact factor: 2.183

4.  Association of uric acid levels with cardiac syndrome X: A meta-analysis.

Authors:  Wu Zu; Chen-Chen Li; Xin-Yu Wang; Qiu-Shi Li; Bing Liu
Journal:  Front Physiol       Date:  2022-10-03       Impact factor: 4.755

5.  Identification of three genetic variants as novel susceptibility loci for body mass index in a Japanese population.

Authors:  Yoshiki Yasukochi; Jun Sakuma; Ichiro Takeuchi; Kimihiko Kato; Mitsutoshi Oguri; Tetsuo Fujimaki; Hideki Horibe; Yoshiji Yamada
Journal:  Physiol Genomics       Date:  2018-01-12       Impact factor: 3.107

6.  Six novel susceptibility loci for coronary artery disease and cerebral infarction identified by longitudinal exome-wide association studies in a Japanese population.

Authors:  Yoshiki Yasukochi; Jun Sakuma; Ichiro Takeuchi; Kimihiko Kato; Mitsutoshi Oguri; Tetsuo Fujimaki; Hideki Horibe; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2018-06-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.